Autolus Therapeutics plc Total Non Current Liabilities 2011-2026 | AUTL

Annual Total Non Current Liabilities Autolus Therapeutics plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	50.6 M	23.7 M	601 K	1.03 M	758 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
50.6 M	601 K	15.3 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
AbbVie ABBV	81.7 B	$ 208.84	-2.86 %	$ 369 B	USA
AbCellera Biologics ABCL	326 M	$ 3.52	0.28 %	$ 1.05 B	Canada
Grifols, S.A. GRFS	7.22 B	$ 8.24	-0.12 %	$ 6.83 B	Spain
Ascendis Pharma A/S ASND	101 M	$ 229.25	0.44 %	$ 5 B	Danmark
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
ANI Pharmaceuticals ANIP	182 M	$ 74.21	-2.3 %	$ 1.43 B	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Cocrystal Pharma COCP	1.17 M	$ 1.51	48.04 %	$ 17 M	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
BioMarin Pharmaceutical BMRN	635 M	$ 55.5	-3.04 %	$ 10.6 B	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Arcturus Therapeutics Holdings ARCT	30.4 M	$ 8.03	2.29 %	$ 220 M	Israel
Adaptive Biotechnologies Corporation ADPT	263 M	$ 14.81	2.63 %	$ 2.25 B	USA
Altimmune ALT	4.4 M	$ 3.34	7.05 %	$ 294 M	USA
BioNTech SE BNTX	341 M	$ 91.18	1.97 %	$ 27.2 B	Germany
Amgen AMGN	37.2 B	$ 347.94	-1.51 %	$ 187 B	USA
Aurinia Pharmaceuticals AUPH	41.9 M	$ 15.61	0.9 %	$ 2.1 B	Canada
Bristol-Myers Squibb Company BMY	59.9 B	$ 59.6	-2.45 %	$ 121 B	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
BioCryst Pharmaceuticals BCRX	44.7 M	$ 9.02	-3.84 %	$ 1.86 B	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Atea Pharmaceuticals AVIR	69.2 M	$ 5.76	1.95 %	$ 469 M	USA
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Cellectis S.A. CLLS	109 M	$ 3.41	1.19 %	$ 116 M	France
Biogen BIIB	9.03 B	$ 177.34	-3.5 %	$ 26 B	USA
Axcella Health AXLA	26.4 M	-	-16.42 %	$ 249 M	USA
Axon Enterprise AXON	107 M	$ 412.81	-2.54 %	$ 31.3 B	USA